A
15.23
0.00 (0.00%)
| Previous Close | 15.23 |
| Open | 15.15 |
| Volume | 2,274,890 |
| Avg. Volume (3M) | 3,166,757 |
| Market Cap | 1,377,466,112 |
| Price / Earnings (TTM) | 13.13 |
| Price / Earnings (Forward) | 7.40 |
| Price / Sales | 0.430 |
| Price / Book | 0.440 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2025 |
| Profit Margin | 5.94% |
| Operating Margin (TTM) | 10.19% |
| Diluted EPS (TTM) | 2.04 |
| Quarterly Revenue Growth (YOY) | 0.30% |
| Quarterly Earnings Growth (YOY) | -89.00% |
| Total Debt/Equity (MRQ) | 74.09% |
| Current Ratio (MRQ) | 1.35 |
| Operating Cash Flow (TTM) | 462.46 M |
| Levered Free Cash Flow (TTM) | -276.20 M |
| Return on Assets (TTM) | 5.06% |
| Return on Equity (TTM) | 6.33% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Acadia Healthcare Company, Inc. | Bearish | Bearish |
AIStockmoo Score
1.1
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.13 |
|
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 1.75% |
| % Held by Institutions | 109.93% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Khrom Capital Management Llc | 30 Sep 2025 | 5,037,448 |
| Abrams Bison Investments, Llc | 30 Sep 2025 | 4,380,000 |
| Sachem Head Capital Management Lp | 30 Sep 2025 | 4,215,000 |
| Maverick Capital Ltd | 30 Sep 2025 | 3,006,505 |
| Hawk Ridge Capital Management Lp | 30 Sep 2025 | 2,805,463 |
| Engine Capital Management, Lp | 30 Sep 2025 | 2,585,574 |
| P2 Capital Partners, Llc | 30 Sep 2025 | 2,337,188 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 27.00 (Guggenheim, 77.28%) | Buy |
| Median | 17.00 (11.62%) | |
| Low | 13.00 (B of A Securities, -14.64%) | Sell |
| Average | 18.75 (23.11%) | |
| Total | 6 Buy, 5 Hold, 1 Sell | |
| Avg. Price @ Call | 14.50 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Jefferies | 22 Jan 2026 | 15.00 (-1.51%) | Hold | 15.15 |
| TD Cowen | 16 Jan 2026 | 22.00 (44.45%) | Buy | 11.68 |
| RBC Capital | 14 Jan 2026 | 17.00 (11.62%) | Buy | 11.73 |
| 03 Dec 2025 | 19.00 (24.75%) | Buy | 14.69 | |
| Mizuho | 18 Dec 2025 | 17.00 (11.62%) | Hold | 14.43 |
| Barclays | 04 Dec 2025 | 14.00 (-8.08%) | Hold | 14.64 |
| 06 Nov 2025 | 17.00 (11.62%) | Hold | 20.26 | |
| B of A Securities | 03 Dec 2025 | 13.00 (-14.64%) | Sell | 14.69 |
| Cantor Fitzgerald | 03 Dec 2025 | 17.00 (11.62%) | Hold | 14.69 |
| 07 Nov 2025 | 22.00 (44.45%) | Hold | 19.51 | |
| Deutsche Bank | 03 Dec 2025 | 20.00 (31.32%) | Buy | 14.69 |
| Keybanc | 03 Dec 2025 | 25.00 (64.15%) | Buy | 14.69 |
| 18 Nov 2025 | 30.00 (96.98%) | Buy | 15.01 | |
| Leerink Partners | 03 Dec 2025 | 14.00 (-8.08%) | Hold | 14.69 |
| UBS | 03 Dec 2025 | 24.00 (57.58%) | Buy | 14.69 |
| 07 Nov 2025 | 28.00 (83.85%) | Buy | 19.51 | |
| Guggenheim | 10 Nov 2025 | 27.00 (77.28%) | Buy | 18.17 |
| Show more | ||||
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 20 Jan 2026 | Announcement | Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer |
| 06 Jan 2026 | Announcement | Acadia Healthcare to Participate in 44th Annual J.P. Morgan Healthcare Conference |
| 02 Dec 2025 | Announcement | Acadia Healthcare Updates PLGL Reserves Following Annual Actuarial Review, Lowers 2025 Guidance |
| 10 Nov 2025 | Announcement | Acadia Healthcare to Participate in UBS 2025 Global Healthcare Conference |
| 05 Nov 2025 | Announcement | Acadia Healthcare Reports Third Quarter 2025 Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |